Search academic texts

Information × Registration Number 0216U000681, 0111U003471 , R & D reports Title To develop efficient methods for developing high-yielding edible and medicinal mushroom varieties resistant to stresses, to develop new and to improve the existing energy saving technologies of their cultivation popup.stage_title Head Babayants Olga Vadymivna, Registration Date 18-02-2016 Organization Plant breeding and genetics institute-National center of seed and cultivar investigation popup.description2 Object of study: isolates, strains macromycetes, mushrooms varieties, their productivity and resistance to pests and pathogens. The aim of the study: to create new varieties of edible and medicinal mushroom which by performance, perseverance and adaptability are better than foreign analogues. To develop advanced cultivation Technologies of the macromycetes to create biological additives and for use them in pharmaceuticals. Research Methods: hybridological analysis, Mycological analysis according to standard methods and own development.Theoretical and practical results: was created genetic resources bank with many wild macromycetes strains: 540 Pleurotus osteratus(P. pulmonaris), 25 - Pleurotus eryngii. 14 - Pleurotus сornucopiae, 12 –Pleurotus cytrinopileatus 9 Pleurotus djamor, 56 - lentinula edodes, 179 - Flamulina velutipes, 56- Ganoderma Lucidum, 8 – Ganoderma applanatum, 13 – Phalus impudicus, 32 – Hericium erinaceum, 30 – Grifola frondosa, 33 – Grametes (Coriolus) versicolor, 19 – Kuechneromices mutabilis. 25 – Laetiporus sulphureus. Was Selected the forms whys the best indicators of resistance to disease, the best accumulation of biologically active substances in fruit bodies and biomass. It was Pleurotus osteratus, lentinula edodes, Flamulina velutipes, Ganoderma Lucidum, Grifola frondosa, Hericium erinaceum. Varieties have been thoroughly tested, and some of Phalus impudicus was most perspective. Was Improved technology in vitro to cultivated species Phalus impudicus to use in the pharmaceutical industry. Was Created a variety of medicinal and edible macromycetes. All the macromycete species have been studied for their medicinal and healing properties. they constitute a rich source of bioactive compounds exhibiting polysaccharides and fatty acids. Novelty: Phalus impudicus have been “domesticated” for the first time in world practice. Was selected at least 4 better types of liquid media with different amount of coffee sludge. Slurry of coffee increases physiological activity of of the rainbow, maitake and heritsiya. Was created the first national variety of: maitake – Mіrazh, Reishi – Lekar, polypore – Mobіlіs, honey agaric summer – Lisovychok, oyster - Iceberg Chornomorskyj and Chаjka Chornomorska, shiitake - Pіk Chornomorsky and Gorez, honey agaric winter – Sonechko. All of them have unique characteristics. Efficiency of the Implementation: Our proven substrate decontamination technology (optimization of microwave devices using) can significantly reduce energy consumption, time and the capital expenses. New disease resistant varieties characterized by high productivity, adaptability and endurance. In addition, range-expanding fungal-species to grown under artificial conditions will be much increase. The introduction of macromycetes growing technology allows pharmaceutical industry to receive high quality raw materials. Product Description popup.authors Бабаянц Ольга Вадимівна popup.nrat_date 2020-04-02 Close